Semaglutide for weight loss in teens with autism
Part of Hormones & metabolism, Mental health clinical trials.
This study tests a medication called semaglutide (a once-a-week injection) to help teenagers with autism who have obesity lose weight and improve their body composition. It compares their results to a group of similar teens who didn't take the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Youth must be 12 to 18 years old.
- Must have a confirmed diagnosis of Autism Spectrum Disorder (ASD).
- Must have obesity, defined as a BMI at or above the 95th percentile for their age and sex. BMI is a measure of body size based on height and weight.
- Insurance (like Medicaid) must cover the study drug, or the parent must be willing to pay for it themselves.
- Must be able to attend visits (in-person, online, or by video) for 12 months.
- Must not have type 1 or type 2 diabetes, or certain other health conditions that could interfere with safety.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study looks at how teenagers and young adults respond to weight-loss surgery (sleeve gastrectomy) and whether adding a medication called semaglutide can help improve weight loss. It has two parts: first observing how surgery affects you, then testing if semaglutide helps those who didn't lose enough weight after surgery.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This study looks at the experiences of people using injectable semaglutide for weight loss, as well as the doctors who prescribe it. It aims to understand how the treatment works in everyday life.
This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.
This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.